Opportunistic Infections  >>  stavudine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
stavudine / Generic mfg.
NCT00055120: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Completed
4
283
US, RoW
Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, AIDS-Related Opportunistic Infections
09/06
08/07
NCT00342355: Antiretroviral Therapy for Advanced HIV Disease in South Africa

Completed
4
1771
RoW
Zidovudine, AZT, Stavudine, D4T, Didanosine, DDI, Lamivudine, 3TC, Efavirenz, EFV, Lopinavir/Ritonavir, Kaletra
National Institutes of Health Clinical Center (CC)
HIV
03/08
08/08

Download Options